3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Cerebellar Ataxia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dichgans, J; Jauch, M; Klockgether, T; Müller-Schauenburg, W; Petersen, D; Schulz, JB; Spieker, S; Voigt, K | 1 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Cerebellar Ataxia
Article | Year |
---|---|
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT.
Topics: Adult; Aged; Benzamides; Brain; Cerebellar Ataxia; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine; Tomography, Emission-Computed, Single-Photon | 1994 |